Analysts Set Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Target Price at $28.00

Shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) have been assigned a consensus rating of “Reduce” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $28.00.

FMS has been the topic of a number of recent research reports. Zacks Research raised Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Morgan Stanley reissued an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Wednesday, May 6th. Wall Street Zen cut Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Weiss Ratings lowered Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, May 7th. Finally, Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research report on Friday, May 8th.

Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in FMS. Moran Wealth Management LLC raised its holdings in Fresenius Medical Care AG & Co. KGaA by 31.5% in the 1st quarter. Moran Wealth Management LLC now owns 347,773 shares of the company’s stock worth $7,846,000 after purchasing an additional 83,311 shares in the last quarter. Pzena Investment Management LLC boosted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 2.0% during the 1st quarter. Pzena Investment Management LLC now owns 15,052,822 shares of the company’s stock valued at $339,592,000 after purchasing an additional 299,986 shares in the last quarter. ABC Arbitrage SA boosted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 1,136.0% during the 4th quarter. ABC Arbitrage SA now owns 249,800 shares of the company’s stock valued at $5,950,000 after purchasing an additional 229,589 shares in the last quarter. Ritholtz Wealth Management increased its position in shares of Fresenius Medical Care AG & Co. KGaA by 252.7% during the first quarter. Ritholtz Wealth Management now owns 84,658 shares of the company’s stock valued at $1,910,000 after buying an additional 60,652 shares during the period. Finally, XY Capital Ltd purchased a new position in shares of Fresenius Medical Care AG & Co. KGaA during the third quarter valued at about $978,000. 8.37% of the stock is currently owned by institutional investors.

Fresenius Medical Care AG & Co. KGaA Price Performance

Shares of Fresenius Medical Care AG & Co. KGaA stock opened at $24.16 on Friday. The company has a current ratio of 1.20, a quick ratio of 0.86 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $12.97 billion, a PE ratio of 12.71, a price-to-earnings-growth ratio of 4.41 and a beta of 0.78. The business’s 50-day moving average price is $22.59 and its 200-day moving average price is $22.85. Fresenius Medical Care AG & Co. KGaA has a 12 month low of $20.02 and a 12 month high of $27.64.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last issued its earnings results on Tuesday, March 31st. The company reported $1.05 earnings per share (EPS) for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%.The business had revenue of $5.34 billion during the quarter. Sell-side analysts forecast that Fresenius Medical Care AG & Co. KGaA will post 2.24 EPS for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The company also recently announced an annual dividend, which was paid on Monday, June 8th. Stockholders of record on Friday, May 22nd were issued a $0.8716 dividend. This is a positive change from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. This represents a dividend yield of 402.0%. The ex-dividend date was Friday, May 22nd. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio (DPR) is 31.58%.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.